All Peptides

A synthetic pentadecapeptide derived from human gastric juice, studied for its regenerative and protective properties.

A synthetic growth hormone-releasing hormone (GHRH) analog studied for growth hormone stimulation.

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, studied for its telomerase-activating, anti-aging, and pineal gland regulatory pr…

A naturally occurring copper peptide with roles in wound healing, anti-aging, and tissue remodeling.

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

A tripeptide (Lys-Pro-Val) derived from alpha-MSH, studied for its anti-inflammatory, wound healing, and gut protective properties.

A mitochondria-derived peptide encoded in the mitochondrial 12S rRNA, studied for its roles in metabolic regulation, insulin sensitivity, and longevit…

A tripeptide (Glu-Asp-Arg) derived from the pineal gland, studied for neuroprotective properties, cognitive enhancement, and anti-aging effects.

A melanocortin receptor agonist studied for sexual dysfunction. FDA-approved as bremelanotide.

A triple agonist of GIP, GLP-1, and glucagon receptors being investigated for obesity and type 2 diabetes treatment.

A synthetic analog of the immunomodulatory peptide tuftsin, studied for anxiolytic and nootropic effects.

A GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management.

A synthetic peptide analog of ACTH(4-10) developed in Russia, studied for nootropic, neuroprotective, and anxiolytic effects.

A mitochondria-targeted antioxidant peptide studied for its ability to reduce oxidative stress, improve mitochondrial function, and protect against is…

A synthetic peptide fragment of thymosin beta-4, researched for wound healing and tissue repair.

A synthetic GHRH analog FDA-approved for HIV-associated lipodystrophy, studied for visceral fat reduction and cognitive effects.

A dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and obesity.